// App-Quantinova.ai

2201 : Tea nanoparticle, a safe and biocompatible nanocarrier, greatly potentiates the anticancer activity of doxorubicin

Researchers

Presenter

  • Yi-Jun Wang

Principal Investigators

  • Yujian Huang

  • Nagaraju Anreddy

  • Guan-Nan Zhang

  • Yun-Kai Zhang

  • Meina Xie

  • Derrick Lin

  • Dong-Hua Yang

  • Mingjun Zhang

  • Zhe-Sheng Chen

Medical Centers

  • St. John's University, Queens, NY

  • The Ohio State Univerisity, Columbus, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Thrombocytopenia

  • Cardiotoxicity

  • Neutropenia

  • Solid malignancies

Biomarkers

  • ATP Binding Cassette Transporter B1

Drug/Treatment

  • Doxorubicin

Outcome

  • N/A

Study Design

  • Pharmacokinetics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved